Suppr超能文献

相似文献

1
Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.
Neurology. 2010 Jan 12;74(2):113-20. doi: 10.1212/WNL.0b013e3181c918cb.
2
Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease.
Neurology. 2011 Mar 1;76(9):822-9. doi: 10.1212/WNL.0b013e31820e7b74.
3
Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism.
Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19067-72. doi: 10.1073/pnas.0705036104. Epub 2007 Nov 14.
4
Structural brain changes in normal individuals with a maternal history of Alzheimer's.
Neurobiol Aging. 2011 Dec;32(12):2325.e17-26. doi: 10.1016/j.neurobiolaging.2011.01.001. Epub 2011 Feb 12.
5
Effect of Alzheimer disease risk on brain function during self-appraisal in healthy middle-aged adults.
Arch Gen Psychiatry. 2007 Oct;64(10):1163-71. doi: 10.1001/archpsyc.64.10.1163.
6
Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults.
Neurology. 2012 May 29;78(22):1769-76. doi: 10.1212/WNL.0b013e3182583047. Epub 2012 May 16.
7
Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD.
Neurology. 2014 Mar 4;82(9):752-60. doi: 10.1212/WNL.0000000000000181. Epub 2014 Feb 12.
8
Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease.
Neurology. 2009 Feb 10;72(6):513-20. doi: 10.1212/01.wnl.0000333247.51383.43. Epub 2008 Nov 12.
10
Impact of APOE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults.
Neurobiol Aging. 2016 Feb;38:14-20. doi: 10.1016/j.neurobiolaging.2015.10.018. Epub 2015 Nov 10.

引用本文的文献

1
TOMM40 may mediate GFAP, neurofilament light Protein, pTau181, and brain morphometry in aging.
Aging Brain. 2024 Dec 13;7:100134. doi: 10.1016/j.nbas.2024.100134. eCollection 2025.
3
Visual Impairment, Eye Conditions, and Diagnoses of Neurodegeneration and Dementia.
JAMA Netw Open. 2024 Jul 1;7(7):e2424539. doi: 10.1001/jamanetworkopen.2024.24539.
4
Automated detection of Alzheimer's disease: a multi-modal approach with 3D MRI and amyloid PET.
Sci Rep. 2024 Mar 3;14(1):5210. doi: 10.1038/s41598-024-56001-9.
5
Alzheimer's disease cortical morphological phenotypes are associated with TOMM40'523-APOE haplotypes.
Neurobiol Aging. 2023 Dec;132:131-144. doi: 10.1016/j.neurobiolaging.2023.09.001. Epub 2023 Sep 11.
10

本文引用的文献

1
Cardiorespiratory fitness and preserved medial temporal lobe volume in Alzheimer disease.
Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):188-97. doi: 10.1097/WAD.0b013e31819cb8a2.
2
The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life.
Neurology. 2009 Sep 1;73(9):665-73. doi: 10.1212/WNL.0b013e3181b01077. Epub 2009 Jul 8.
3
Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study.
J Alzheimers Dis. 2009;18(3):553-64. doi: 10.3233/JAD-2009-1163.
4
Factors associated with resistance to dementia despite high Alzheimer disease pathology.
Neurology. 2009 Jan 27;72(4):354-60. doi: 10.1212/01.wnl.0000341273.18141.64.
6
Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease.
Neurology. 2009 Feb 10;72(6):513-20. doi: 10.1212/01.wnl.0000333247.51383.43. Epub 2008 Nov 12.
8
Magnetic resonance imaging traits in siblings discordant for Alzheimer disease.
J Neuroimaging. 2008 Jul;18(3):268-75. doi: 10.1111/j.1552-6569.2007.00191.x.
9
Cardiorespiratory fitness and brain atrophy in early Alzheimer disease.
Neurology. 2008 Jul 15;71(3):210-6. doi: 10.1212/01.wnl.0000317094.86209.cb.
10
VBM anticipates the rate of progression of Alzheimer disease: a 3-year longitudinal study.
Neurology. 2008 Jun 3;70(23):2201-11. doi: 10.1212/01.wnl.0000303960.01039.43. Epub 2008 Apr 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验